European equities traded in the US as American depositary receipts were falling on Thursday morning, down 0.2% to 1,525.94 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by insurer Aegon (AEG) and biopharmaceutical firm DBV Technologies (DBVT), which rose 7.2% and 4.1%, respectively.
They were followed by biotech firm Evaxion (EVAX) and pharmaceutical giant Novo Nordisk (NVO), which added 2.7% and 2.1%.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and steel maker ArcelorMittal (MT), which fell 3.2% and 2.7%, respectively.
From the UK and Ireland, the gainers were led by pharmaceutical companies Adaptimmune Therapeutics (ADAP) and Centessa Pharmaceuticals (CNTA), which rose 5.4% and 1.8%, respectively.
The decliners from the UK and Ireland were led by cryptocurrency miner Argo Blockchain (ARBK), which was down 2.5%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。